p38α Mitogen-activated Protein Kinase Sensitizes Cells to Apoptosis Induced by Different Stimuli

Mice, Knockout STAT3 Transcription Factor 0303 health sciences MAP Kinase Signaling System Apoptosis Fibroblasts Embryo, Mammalian DNA-Binding Proteins Enzyme Activation Mitogen-Activated Protein Kinase 14 Mice 03 medical and health sciences Proto-Oncogene Proteins c-bcl-2 Proto-Oncogene Proteins Trans-Activators Animals Myocytes, Cardiac Mitogen-Activated Protein Kinases Phosphorylation Cells, Cultured Signal Transduction bcl-2-Associated X Protein
DOI: 10.1091/mbc.e03-08-0592 Publication Date: 2003-11-18T01:23:24Z
ABSTRACT
p38α mitogen-activated protein (MAP) kinase is a broadly expressed signaling molecule that participates in the regulation of cellular responses to stress as well as in the control of proliferation and survival of many cell types. We have used cell lines derived from p38α knockout mice to study the role of this signaling pathway in the regulation of apoptosis. Here, we show that cardiomyocytes and fibroblasts lacking p38α are more resistant to apoptosis induced by different stimuli. The reduced apoptosis of p38α-deficient cells correlates with decreased expression of the mitochondrial proapoptotic protein Bax and the apoptosis-inducing receptor Fas/CD-95. Cells lacking p38α also have increased extracellular signal-regulated kinase (ERKs) MAP kinase activity, and the up-regulation of this survival pathway seems to be at least partially responsible for the reduced levels of apoptosis in the absence of p38α. Phosphorylation of the transcription factor STAT3 on Ser-727, mediated by the extracellular signal-regulated kinase MAP kinase pathway, may contribute to the decrease in both Bax and Fas expression in p38α-/- cells. Thus, p38α seems to sensitize cells to apoptosis via both up-regulation of proapoptotic proteins and down-regulation of survival pathways.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (71)
CITATIONS (196)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....